Role of LH and hCG in adults being evaluated for endocrine disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates associations between blood LH and hCG levels and the presence, severity, and long-term outcomes of various endocrine disorders in adults. Participants are adults aged 18 to 90 referred to or followed at the Department of Endocrinology and Internal Medicine, Herlev Hospital. The study does not specify an intervention but aims to characterize hormonal patterns across conditions such as osteoporosis, hypercalcemia, primary hyperparathyroidism, adrenal disease, and pituitary disease. The approach relies on measuring circulating LH and hCG and correlating these levels with clinical data and disease trajectories. Outcomes of interest include symptom burden, disease progression, and potentially long-term health implications tied to menopausal or age-related hormonal changes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients referred to or patients actively followed at the Department of Endocrinology and Internal Medicine at Herlev Hospital
* Age 18-90

Exclusion Criteria:

* Lacking mental capacity to provide informed consent

Where it's running

• Department of Endocrinology and Internal Medicine, Herlev Hospital
  Herlev, Denmark Recruiting

Study contacts

• Study coordinator: Martin B Jensen, Professor
• Email: martin.blomberg.jensen@regionh.dk
• Phone: +4538687318

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using calcitonin to enhance SPECT-CT imaging for parathyroid adenoma localization

  This study is testing if giving calcitonin to patients with primary hyperparathyroidism before a second SPECT-CT scan can help doctors find parathyroid adenomas that were missed in the first scan.

  Recruiting Phase 4 ProMedica Health System · Toledo, Ohio · NCT03935984

• Postoperative outcomes after thyroidectomy: ERAS vs standard care

  This study tests whether an enhanced recovery after surgery (ERAS) protocol helps adults 18–60 undergoing thyroidectomy recover faster and leave the hospital sooner compared with a local non-ERAS regimen.

  Recruiting Allied Hospital Faisalabad · Faisalabad, Punjab Province · NCT07915960

• ETHY-001 safety and activity in Thyroid Eye Disease (TED)

  This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.

  Recruiting at 2 sites Phase 1 Ethyreal Bio, Inc. · Orland Park, Illinois and 2 other locations · NCT07885605

• NIRAF imaging to help parathyroid removal when preoperative tests don’t locate glands

  This trial tests whether using an NIRAF camera during parathyroid surgery helps find and remove abnormal glands in people with primary hyperparathyroidism when prior imaging hasn’t pinpointed them.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07812649

• WeChat-supported neck exercises after thyroidectomy

  A telehealth program using a WeChat mini program tests if guided neck exercises after thyroid surgery help early recovery and quality of life.

  Recruiting Shanghai 6th People's Hospital · Shanghai, Shanghai Municipality · NCT07707401

• Can a blood marker called lumican reveal hidden fragility in postmenopausal osteoporosis

  This study tests whether serum lumican levels can help identify hidden fragility risk in postmenopausal women beyond what bone density shows.

  Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Küçükçekmece, Istanbul · NCT07677072

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.